Alberto-Culver becoming a rarity in personal care as a large independent: stock index.
This article was originally published in The Rose Sheet
Executive Summary
ALBERTO STANDS ALONE AMIDST CONSOLIDATION FLURRY IN FIRST HALF, raising the question of how the firm will continue to grow sales and profits in the face of drug store consolidation and the ever-increasing marketing budgets from competition with greater financial resources. Alberto-Culver, already one of the last predominantly family run, large diversifieds in the industry, is looking even more rare in light of the stepped-up acquisition activity in the first half that brought Redmond Products under the Bristol-Myers Squibb umbrella and Freeman Cosmetic into the arms of Dial.